Option Care Health (NASDAQ:OPCH) reported second-quarter 2026 results that exceeded its internal expectations, with revenue, adjusted EBITDA and adjusted earnings per share all improving sequentially. For the third quarter, Option Care expects sequential revenue growth in the low- to mid-single-digit range and sequential adjusted EBITDA growth in the mid-single-digit range. Rademacher noted that Option Care remains broadly in network with payers and PBMs and continues to pursue site-of-care initiatives with national and regional health plans. About Option Care Health (NASDAQ:OPCH)Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.